Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)

Condition:   Metastatic Castration Resistant Prostate Cancer Interventions:   Drug: Rucaparib;   Drug: Enzalutamide;   Drug: Abiraterone Sponsor:   Clovis Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials